Endocrine Society and Keystone Symposia Announce Series of Joint Meetings

The Endocrine Society and Keystone Symposia are partnering to hold a series of joint translation scientific meetings that connect foundational (or basic) science with clinical practice across oncology, cardiometabolism, and diabetes with the aim of supporting a full bench-to-bedside and back research cycle.

Keystone Symposia contributes deep connections to basic scientists and a robust infrastructure for large-scale scientific meetings, while the Endocrine Society brings clinical expertise and its scholarly journals with plans to publish conference proceedings or abstracts to attract scientists who currently lack such outlets through Keystone Symposia.

“At the heart of [this partnership] is trying to facilitate areas of discovery because there are so many meetings out there for basic scientists, but some of them may have deviated from the core intent, which is really to advance science and facilitate those types of breakthroughs,” says Chris Urena, MBA, FASAE, CAE, the Endocrine Society’s chief learning officer.

 The conferences are designed to inspire discovery and collaboration among basic and translational researchers, with the goal of catalyzing advances in foundational science. Ultimately, these discoveries can lead to breakthroughs that improve clinical outcomes for patients. 

By combining the resources of two top scientific organizations, the Endocrine Society and Keystone Symposia are strengthening the exchange of scientific knowledge through coordinated programming. The conferences are designed to inspire discovery and collaboration among basic and translational researchers, with the goal of catalyzing advances in foundational science. Ultimately, these discoveries can lead to breakthroughs that improve clinical outcomes for patients. 

“One of the things that we’re trying to get better at, both groups together, is how do we facilitate spaces that have this full cycle of beds to bedside, bedside back to bed,” Urena says. “And in that there are those three programs or three topics that surface, oncology, cardiombetabolism, and diabetes.”

Three inaugural programs will begin in October 2026 and run through February 2027. The series includes:

• Hormonal Influences on Immunity and Cancer Across the Lifespan (October 5 –8, 2026 | Breckenridge, Colo.) brings together researchers across endocrinology, aging, and oncology to examine how hormonal signaling shapes disease in ways that are often overlooked when studied in isolation. Registration opens in late June. 
• Reimagining Diabetes: From Molecular Mechanisms to Transformative Therapies (February 1 – 4, 2027 | Keystone, Colo.) connects basic science, clinical research, and industry perspectives to better understand disease drivers and identify new therapeutic strategies. 
• Cardiometabolism and Interorgan Crosstalk: Novel Mechanisms and Therapies (February 16 – 19, 2027 | Breckenridge, Colo.) explores how communication across organ systems influences disease, highlighting emerging insights from genetics, immunology, and computational biology. 

Amid a challenging research funding climate, the Society and Keystone will explore the importance of strategic partnerships in scientific discovery during a joint symposium at ENDO 2026, on June 16 in Chicago, Ill. The joint panel, “Keystone Symposia + Endocrine Society: How Partnerships Across the Life Sciences Benefit Researchers,” will feature researchers Ines Pineda Torra, PhD; David D’Alessio, MD; Jennifer K. Richer, PhD; and Roger Cone, PhD. The session, co-moderated by Urena and Keystone Symposia’s President and CEO James Baumgartner, PhD, will address how clinical observations shape research questions as well as mechanistic insights that guide new approaches to care — and how these ideas will come together in three upcoming meetings.

Urena says the above group is essentially the planning board, one that Keystone facilitates. “It’s a good composite of people who are practitioners in terms of scientists, MDs, PhDs, some with both, but then also people from industry,” he says.

The partners anticipate that a contracting scientific meeting marketplace will create opportunities for more integrated joint offerings, including calls for papers and expanded engagement of endocrine-adjacent fields, with added value from clinical perspectives and publication pathways. “I think that’s a pretty interesting take on it,” Urena says. “And the advantage of working with Keystone is they have not only the connections to basic scientists, but they have a really proficient apparatus to stand up these scientific meetings at a scale that we just don’t have yet.”

By combining the resources of two top scientific organizations, the Endocrine Society and Keystone Symposia are strengthening the exchange of scientific knowledge through coordinated programming.

“These conferences provide a valuable opportunity for researchers across the endocrine spectrum to engage deeply, challenge assumptions, and inspire new directions in science,” says Endocrine Society president Carol Lange, PhD. “We are proud to partner with Keystone Symposia in the spirit of advancing science. By bringing discovery and translation together, we are strengthening the pipeline from innovation to patient care.”

The post Endocrine Society and Keystone Symposia Announce Series of Joint Meetings appeared first on Endocrine News.